Press release
Asthma Clinical Trials Assessment 2024: FDA Approvals, Drugs, Clinical Trials, Therapeutic Analysis, and Companies by DelveInsight
Asthma Clinical Trials
Key Takeaways from the Asthma Pipeline Report
• DelveInsight's Asthma pipeline report depicts a robust space with 90+ active players working to develop 100+ pipeline therapies for Asthma treatment.
• The leading companies working in the Asthma Market include Jiangsu Hengrui Medicine, GlaxoSmithKline, Immunotek SL, AB Science, EMS, Avalo Therapeutics, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., ARS Pharmaceuticals, Sanofi, Zura Bio Ltd., AstraZeneca, EURRUS Biotech GmbH, T-Balance Therapeutics GmbH, Gossamer Bio, Aldeyra Therapeutics, Inc., Trio Medicines, Janssen Research & Development, Arrowhead Pharmaceuticals, Hoffman-La-Roche, GlaxoSmithKline, Biohaven Pharmaceutical, TAK-Circulator Co., Shanghai Hengrui Pharmaceutical, and others.
• Promising Asthma Pipeline Therapies in the various stages of development include DUPIXENT®, Tezepelumab, MEDI9929, Revamilast, Benralizumab, AZD7594, GSK3511294 (Depemokimab), and others.
• April 2024: AstraZeneca- A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants With Severe Asthma Including Several Under-Studied Populations in the United States (PASSAGE).
• March 2024: Bond Avillion 2 Development LP- A Multicenter, Randomized, Double-blind, Parallel-group, Event-driven, Decentralized, Phase IIIb Study Comparing PT027 With PT007 Administered as Needed in Participants 12 Years of Age and Older With Asthma (BATURA).
Request a sample and discover the recent advances in Asthma Treatment Drugs @ Asthma Pipeline Outlook Report- https://www.delveinsight.com/sample-request/asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
In the Asthma pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Asthma collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Asthma Overview
Asthma is a chronic disease that affects the airways. Asthma is characterized by inflammation and spasm of the airways. The airways are tubes that carry air in and out of the lungs. If a person has asthma, the inside walls of the airways become sore and swollen.
Find out more about Asthma Treatment Landscape @ Drugs for Asthma Treatment- https://www.delveinsight.com/sample-request/asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Asthma Emerging Drugs Profile
• Dexpramipexole: Areteia Therapeutics
• TQC2731: Chia Tai Tianqing Pharmaceutical Group
• SHR-1703: Jiangsu HengRui Medicine
Asthma Pipeline Therapeutics Assessment
There are approx. 100+ key companies which are developing the Asthma therapies. The Asthma Companies which have their Asthma drug candidates in the most advanced stage, i.e. phase III include, Areteia Therapeutics.
DelveInsight's Asthma pipeline report covers around 100+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Asthma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
Asthma Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Learn more about the emerging Asthma Pipeline Therapies @ Asthma Clinical Trials Assessment- https://www.delveinsight.com/sample-request/asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Asthma Pipeline Report
• Coverage- Global
• Asthma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Asthma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Asthma Companies- Jiangsu Hengrui Medicine, GlaxoSmithKline, Immunotek SL, AB Science, EMS, Avalo Therapeutics, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., ARS Pharmaceuticals, Sanofi, Zura Bio Ltd., AstraZeneca, EURRUS Biotech GmbH, T-Balance Therapeutics GmbH, Gossamer Bio, Aldeyra Therapeutics, Inc., Trio Medicines, Janssen Research & Development, Arrowhead Pharmaceuticals, Hoffman-La-Roche, GlaxoSmithKline, Biohaven Pharmaceutical, TAK-Circulator Co., Shanghai Hengrui Pharmaceutical, and others.
• Asthma Pipeline Therapies- DUPIXENT®, Tezepelumab, MEDI9929, Revamilast, Benralizumab, AZD7594, GSK3511294 (Depemokimab), and others.
Dive deep into rich insights for new drugs for Asthma Treatment, Visit @ Asthma Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Introduction
2. Asthma Executive Summary
3. Asthma: Overview
4. Asthma Pipeline Therapeutics
5. Asthma Pipeline Therapeutic Assessment
6. Asthma - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. PT-027: Avillion LLP
9. Mid Stage Products (Phase II/III)
10. PT001: Pearl Therapeutics (AstraZeneca)
11. Mid Stage Products (Phase II)
12. FP 025: Foresee Pharmaceuticals
13. Early Stage Products (Phase I/II)
14. AQ-001S: Aquilon Pharmaceuticals S.A
15. Early Stage Products (Phase I)
16. Itolizumab (EQ001): Equillium
17. Preclinical and Discovery Stage Products
18. KBP7026: KBP Biosciences
19. Inactive Products
20. Asthma Key Companies
21. Asthma Key Products
22. Asthma- Unmet Needs
23. Asthma- Market Drivers and Barriers
24. Asthma- Future Perspectives and Conclusion
25. Asthma Analyst Views
26. Asthma Key Companies
27. Appendix
For further information on the Asthma Pipeline Therapeutics, reach out @ Asthma Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/asthma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• 3d Cardiac Mapping System Market: https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market
• Absssi Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Acute Intermittent Porphyria Market: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
• Acute Ischemic Stroke Ais Market: https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
• Acute On Chronic Liver Failure Aclf Market: https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market
• Adrenal Insufficiency Market: https://www.delveinsight.com/report-store/adrenal-crisis-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Anemia In Ckd Market: https://www.delveinsight.com/report-store/anemia-in-chronic-kidney-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/anti-cd274-pd-l1-antibody-pipeline-insight
• Antiphospholipid Syndrome Aps Market: https://www.delveinsight.com/report-store/antiphospholipid-syndrome-aps-market
• Athlete's Foot Market: https://www.delveinsight.com/report-store/athletes-foot-market
• Biliary Atresia Market: https://www.delveinsight.com/report-store/biliary-atresia-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Car T Therapy For Acute Lymphoblastic Leukemia All Market: https://www.delveinsight.com/report-store/car-t-cell-therapy-for-acute-lymphoblastic-leukemia-market
Contact Us:
Ankit Nigam
Marketing Manager
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asthma Clinical Trials Assessment 2024: FDA Approvals, Drugs, Clinical Trials, Therapeutic Analysis, and Companies by DelveInsight here
News-ID: 3560589 • Views: …
More Releases from DelveInsight Business Research
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease…
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product…
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical…
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth.
DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices…
More Releases for Asthma
Evolving Market Trends In The Asthma Spacers Industry: Smart Inhaler Devices Rev …
The Asthma Spacers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Asthma Spacers Market Size During the Forecast Period?
The asthma spacers market has grown steadily, forecasted to rise from $1.88 billion in 2024 to $2.01 billion in 2025 at a CAGR…
Asthma Relief Reimagined: Trends Driving Asthma Spacer Innovation
The Business Research Company recently released a comprehensive report on the Global Asthma Spacers Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Asthma Warning Sensors Market Connected Care for Asthma: How Warning Sensors Imp …
Asthma Warning Sensors Market Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Asthma Warning Sensors Market Size, Share & Trends Analysis Report By Type (Wearable v/s Non-Wearable), By Technology (AI, IoT, Machine Learning, Others), By Parameter Measured (FEV1 v/s Peak Flow), By End User (Hospitals & Clinics v/s Homecare)- Market…
Asthma Spacers Market Optimizing Asthma Treatment: How Spacers are Improving Del …
Asthma Spacers Market Assessment worth $ 2.47 Billion by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Asthma Spacers Market- by Product (Space Chamber Plus, A2A Spacer, Flo-Tone CR, Able Spacer, AeroChamber, Volumatic, Vortex, OptiChamber), Application (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get a free sample copy of…
Severe Asthma Treatment Market - Revitalizing Quality of Life: Severe Asthma Tre …
Newark, New Castle, USA: The "Severe Asthma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Severe Asthma Treatment Market: https://www.growthplusreports.com/report/severe-asthma-treatment-market/8939
This latest report researches the industry structure,…
Asthma Monitoring Devices Market - Revolutionizing Asthma Care: Elevate Monitori …
Newark, New Castle, USA: The "Asthma Monitoring Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Asthma Monitoring Devices Market: https://www.growthplusreports.com/report/asthma-monitoring-devices-market/8697
This latest report researches the industry structure,…
